Bufo Bufo Toad Venom For Sale

Bufo bufo toad venom European toad, produces venom from paired parotoid glands behind the eyes and from smaller granular glands across the skin. Bufo bufo venom DMT venom is a milky secretion released defensively when the toad is threatened. Unlike snakes and scorpions, toads are not aggressive envenomators; exposure typically occurs through skin contact, ingestion by predators, or accidental contact with eyes and mouth.

Bufo venom is a complex mixture of bufadienolides, biogenic amines, and proteins.

1. Bufadienolides are cardiotonic steroids similar to digoxin. They inhibit the Na⁺/K⁺ ATPase pump in cardiac cells, leading to increased intracellular calcium and altered contractility.

2. Biogenic amines such as bufotenin, serotonin, and catecholamines contribute to local irritation, vasoconstriction, and neurostimulation.

3. Proteins and enzymes include hyaluronidases and phospholipases that facilitate spread and cause local tissue irritation.

The exact composition varies by individual, season, and geography, but bufadienolides are the primary cardiotoxic agents.

In humans, direct skin contact usually causes mild irritation, burning, and dermatitis. Accidental ingestion or contact with mucous membranes can produce more severe effects. Symptoms include nausea, vomiting, hypersalivation, abdominal pain, and cardiac arrhythmias such as bradycardia, tachycardia, or heart block. Severe poisoning can lead to hypotension, seizures, and cardiac arrest. In animals, especially dogs that bite toads, bufotoxin poisoning can be fatal within hours if untreated.

There is no specific antivenom for Bufo bufo. Management is supportive and focuses on decontamination, cardiac monitoring, and control of arrhythmias and electrolyte disturbances. Gastric lavage and activated charcoal may be used for recent ingestion. Eye exposure requires thorough irrigation.

The bufadienolides in toad venom are studied for their effects on cardiac function and cell signaling. Some compounds have been investigated for potential use in cancer research, though no clinical applications are approved.